Literature DB >> 12837693

Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells.

Guolin Tan1, Eleonora Napoli, Franco Taroni, Gino Cortopassi.   

Abstract

Inherited deficiency of the mitochondrial protein frataxin causes neural and cardiac cell degeneration, and Friedreich's ataxia. Five hypotheses for frataxin's mitochondrial function have been generated, largely from work in non-human cells: iron transporter, iron-sulfur cluster assembler, iron-storage protein, antioxidant and stimulator of oxidative phosphorylation. We analyzed gene expression in three human cell types using microarrays, and identified just 48 transcripts whose expression was significantly frataxin-dependent in at least two cell types. Significant decreases in seven transcripts occurred in the sulfur amino acid (SAA) biosynthetic pathway and the iron-sulfur cluster (ISC) biosynthetic pathway to which it is connected. By contrast, we did not observe a single frataxin-dependent transcript that fits with the other four current hypotheses. Quantitative reverse-transcriptase PCR analysis of ISC-S and rhodanese transcripts confirmed that the expression of these genes involved in ISC metabolism was lower in mutants. Amino acid analysis confirmed the defect in SAA metabolism: homocystine, cysteine, cystathionine and serine were significantly decreased in frataxin-deficient cell extracts and mitochondria. An ISC defect was further confirmed by observing decreases in succinate dehydrogenase and aconitase activities, whose activities require ISCs. The ISC-U scaffold protein was specifically decreased in frataxin-deficient cells, suggesting a role for frataxin in its expression or maintenance, and sodium sulfide partially rescued the oxidant-sensitivity of the FRDA cells. Also, multiple transcripts involved in the Fas/TNF/INF apoptosis pathway were up-regulated in frataxin-deficient cells, consistent with a multi-step mechanism of Friedreich's ataxia pathophysiology, and suggesting alternative possibilities for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837693     DOI: 10.1093/hmg/ddg187

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  33 in total

1.  A gene expression phenotype in lymphocytes from Friedreich ataxia patients.

Authors:  Giovanni Coppola; Ryan Burnett; Susan Perlman; Revital Versano; Fuying Gao; Heather Plasterer; Myriam Rai; Francesco Saccá; Alessandro Filla; David R Lynch; James R Rusche; Joel M Gottesfeld; Massimo Pandolfo; Daniel H Geschwind
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

Review 2.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

3.  HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis.

Authors:  Yuxi Shan; Gino Cortopassi
Journal:  Hum Mol Genet       Date:  2011-12-13       Impact factor: 6.150

Review 4.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

5.  Gene Expression Profile in Peripheral Blood Cells of Friedreich Ataxia Patients.

Authors:  Agessandro Abrahao; Jose Luiz Pedroso; Patricia Maria de Carvalho Aguiar; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

6.  PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.

Authors:  Daniele Marmolino; Mario Manto; Fabio Acquaviva; Paola Vergara; Ajay Ravella; Antonella Monticelli; Massimo Pandolfo
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 7.  The pathogenesis of Friedreich ataxia and the structure and function of frataxin.

Authors:  Massimo Pandolfo; Annalisa Pastore
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

8.  Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.

Authors:  Nadège Calmels; Hervé Seznec; Pascal Villa; Laurence Reutenauer; Marcel Hibert; Jacques Haiech; Pierre Rustin; Michel Koenig; Hélène Puccio
Journal:  BMC Neurol       Date:  2009-08-24       Impact factor: 2.474

9.  The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.

Authors:  Nadège Calmels; Stéphane Schmucker; Marie Wattenhofer-Donzé; Alain Martelli; Nadège Vaucamps; Laurence Reutenauer; Nadia Messaddeq; Cécile Bouton; Michel Koenig; Hélène Puccio
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

10.  Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

Authors:  Astrid C Haugen; Nicholas A Di Prospero; Joel S Parker; Rick D Fannin; Jeff Chou; Joel N Meyer; Christopher Halweg; Jennifer B Collins; Alexandra Durr; Kenneth Fischbeck; Bennett Van Houten
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.